8-(4-fluorophenyl)-3,4-dihydro-2H-1-benzoxepin-5-one | 141106-46-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: 8-(4-fluorophenyl)-3,4-dihydro-2H-1-benzoxepin-5-one
• CAS: 141106-46-9
• 化学式: C₁₆H₁₃FO₂
• 分子量: 256.276
• InChiKey: UGPWJEPOFQBMIS-UHFFFAOYSA-N

物化性质

• 沸点：
  420.6±44.0 °C(Predicted)
• 密度：
  1.214±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  8-(4-fluorophenyl)-3,4-dihydro-2H-1-benzoxepin-5-one 在 sodium tetrahydroborate 、 对甲苯磺酸 作用下， 以 正己烷 为溶剂， 反应 27.0h， 生成 3-(2,4-Difluoro-phenyl)-1-[8-(4-fluoro-phenyl)-2,3,4,5-tetrahydro-benzo[b]oxepin-5-yl]-1-hexyl-urea
  参考文献：
  名称：

  Synthesis and structure-activity relationships of new ACAT inhibitors

  摘要：

  A series of heterocyclic ureas were synthesized and their ability to inhibit arterial and intestinal ACAT was assessed in animals. The structural modifications carried out in this series led to N-2-(2,4-difluorophenyl)-N-1-8-(4-fluorophenyl)-2,3,4,5-tetrahydro-1-benzoxepin-5-yl-N-1-n-heptylurea 21, which proved to be very active on both the inhibition of aortic ACAT and the inhibition of rat cholesterol intestinal absorption, thus exhibiting a strong hypocholesterolemic effect po in the rat (ED(25) = 0.2 mg/kg).

  DOI：

  10.1016/0223-5234(96)88247-x
• 作为产物：
  描述：

  4'-fluoro-[1,1'-biphenyl]-3-ol 在 sodium hydroxide 、 PPA 作用下， 以 xylene 为溶剂， 反应 9.0h， 生成 8-(4-fluorophenyl)-3,4-dihydro-2H-1-benzoxepin-5-one
  参考文献：
  名称：

  Synthesis and structure-activity relationships of new ACAT inhibitors

  摘要：

  A series of heterocyclic ureas were synthesized and their ability to inhibit arterial and intestinal ACAT was assessed in animals. The structural modifications carried out in this series led to N-2-(2,4-difluorophenyl)-N-1-8-(4-fluorophenyl)-2,3,4,5-tetrahydro-1-benzoxepin-5-yl-N-1-n-heptylurea 21, which proved to be very active on both the inhibition of aortic ACAT and the inhibition of rat cholesterol intestinal absorption, thus exhibiting a strong hypocholesterolemic effect po in the rat (ED(25) = 0.2 mg/kg).

  DOI：

  10.1016/0223-5234(96)88247-x

文献信息

• Synthesis and structure-activity relationships of new ACAT inhibitors
  作者：JY Nioche、J Decerprit、D Festal

  DOI：10.1016/0223-5234(96)88247-x

  日期：1995.1

  A series of heterocyclic ureas were synthesized and their ability to inhibit arterial and intestinal ACAT was assessed in animals. The structural modifications carried out in this series led to N-2-(2,4-difluorophenyl)-N-1-8-(4-fluorophenyl)-2,3,4,5-tetrahydro-1-benzoxepin-5-yl-N-1-n-heptylurea 21, which proved to be very active on both the inhibition of aortic ACAT and the inhibition of rat cholesterol intestinal absorption, thus exhibiting a strong hypocholesterolemic effect po in the rat (ED(25) = 0.2 mg/kg).